A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person
A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person
This study is ongoing, but not recruiting participants.
Sponsored by: State University of New York - Upstate Medical University
Information provided by: State University of New York - Upstate Medical University
ClinicalTrials.gov Identifier: NCT00629434
Purpose
This study compares group diabetes education in-person versus via telemedicine
Condition Intervention
Diabetes Mellitus
Other: diabetes education via telemedicine
Other: diabetes education in-person
MedlinePlus related topics: Diabetes
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Active Control, Parallel Assignment
Official Title: A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person
Further study details as provided by State University of New York - Upstate Medical University:
Primary Outcome Measures:
A1c [ Time Frame: baseline, 3 mo post intervention, 6 mo post intervention ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
PAID scale [ Time Frame: baseline, 3 and 6 months post intervention ] [ Designated as safety issue: No ]
Diabetes Treatment Satisfaction Questionnaire [ Time Frame: Baseline, 3 and 6 months post intervention ] [ Designated as safety issue: No ]
Enrollment: 68
Study Start Date: June 2001
Estimated Study Completion Date: August 2008
Estimated Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
This arm will receive diabetes education via telemedicine Other: diabetes education via telemedicine
This arm will receive diabetes group education via telemedicine
2: Active Comparator
diabetes education in-person Other: diabetes education in-person
In this arm the group of patients with diabetes will receive diabetes education in-person
Detailed Description:
Diabetes education is important in the treatment of the person with diabetes. A diabetes self-management education program not only educates the patient and his/her family to the basics of diabetes care but also integrates diabetes care into daily life while providing coping skills to adjust to this chronic illness. Unfortunately, comprehensive diabetes care is not available to all persons with diabetes. One obstacle to the provision of comprehensive diabetes care is the unavailability of a diabetes treatment center. many people with diabetes live too far or do not have the transportation to be able to attend education programs that met national standards. We have shown that telemedicine is an effective means to provide comprehensive 1:1 individualized diabetes education to persons with diabetes. We now propose to test the hypothesis that diabetes groups education classes can be provided effectively through telemedicine technology to individuals living in rural areas. Patients with diabetes will received diabetes education via teleconferencing from our Joslin Diabetes center. The participants will be assessed before and after diabetes education via telemedicine using measures of glycemia (A1c) and assessments of patient satisfaction, emotional well being, and behavioral change and compared to results from participants attending our diabetes education classes in-person.
Eligibility
Ages Eligible for Study: 18 Years to 85 Years
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria:
Type 1 or type 2 diabetes mellitus
age > 18 years
Exclusion Criteria:
Profound vision loss
Severe hearing impairment
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00629434
Locations
United States, New York
Joslin Diabetes Center Affiliate at SUNY Upstate Medical University
Syracuse, New York, United States, 13214
Sponsors and Collaborators
State University of New York - Upstate Medical University
More Information
Responsible Party: SUNY Upstate Medical University ( Roberto Izquierdo, MD )
Study ID Numbers: UMU IRB # 4510F, UMU IRB # 4510F
First Received: February 25, 2008
Last Updated: March 4, 2008
ClinicalTrials.gov Identifier: NCT00629434
Health Authority: United States: Institutional Review Board
Keywords provided by State University of New York - Upstate Medical University:
Diabetes Education
Telemedicine
Study placed in the following topic categories:
Metabolic Diseases
Diabetes Mellitus
Endocrinopathy
Metabolic disorder
Glucose Metabolism Disorders
Additional relevant MeSH terms:
Endocrine System Diseases
Nutritional and Metabolic Diseases
Diabetes Mellitus
ClinicalTrials.gov processed this record on June 11, 2008
Votes:4
Comments: 0